Stock Events

Stock Events

Bachem 

$76.65
31
+$0+0% Monday 20:00

Statistics

Day High
77
Day Low
77
52W High
77
52W Low
60.51
Volume
100
Avg. Volume
5
Mkt Cap
0
P/E Ratio
32.74
Dividend Yield
0.73%
Dividend
0.56

Upcoming

5
MAY
Dividend Ex
Increased
 
6
MAY
Dividend Payment
Increased
 
5
MAY 27
Dividend Ex
Estimated
 
6
MAY 27
Dividend Payment
Estimated
 
5
MAY 28
Dividend Ex
Estimated
 

Dividends

0.73%Dividend Yield
May 25
$0.52
Apr 24
$0.44
Apr 23
$0.43
May 22
$1.8
May 21
$1.79
10Y Growth
-13.86%
5Y Growth
-21.9%
3Y Growth
6.96%
1Y Growth
N/A

Earnings

12MarExpected
Q2 2023
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
0.39
0.79
1.18
Expected EPS
0.8718191327999999
Actual EPS
N/A

Financials

19.85%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
669.54MRevenue
132.89MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BCHMF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that competes with Bachem in the development and manufacturing of peptide-based therapeutics.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly is a pharmaceutical company with a strong focus on peptide and protein-based drugs, directly competing with Bachem's peptide synthesis services.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk specializes in diabetes care and biopharmaceuticals, including peptide treatments, making it a competitor in the peptide therapeutic market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation that competes with Bachem in the development and production of peptide and protein-based drugs.
Merck
MRK
Mkt Cap214.76B
Merck is a healthcare company that develops peptide-based therapeutics, competing with Bachem in the biopharmaceutical sector.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global pharmaceutical company that develops peptide-based drugs, competing with Bachem in the peptide therapeutics market.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a biopharmaceutical company that competes with Bachem in the development of peptide and protein-based therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that develops peptide and protein-based drugs, competing with Bachem.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including peptide-based therapies, competing with Bachem in the generics and specialty drug market.

About

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland.
Show more...
CEO
Mr. Thomas Meier
Employees
2207
Country
CH
ISIN
CH1176493729

Listings

SW
CH
BANB.SW
OTC Link
US
BCHMY
F
DE
BHM0.F
F
DE
BHM.F

0 Comments

Share your thoughts

FAQ

What is Bachem stock price today?▼
The current price of BCHMF is $76.65 USD — it has increased by +0% in the past 24 hours. Watch Bachem stock price performance more closely on the chart.
What is Bachem stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bachem stocks are traded under the ticker BCHMF.
Is Bachem stock price growing?▼
BCHMF stock has risen by +0% compared to the previous week, the month change is a +26.67% rise, over the last year Bachem has showed a +19.66% increase.
When is the next Bachem earnings date?▼
Bachem is going to release the next earnings report on July 30, 2026.
What is Bachem revenue for the last year?▼
Bachem revenue for the last year amounts to 669.54M USD.
What is Bachem net income for the last year?▼
BCHMF net income for the last year is 132.89M USD.
Does Bachem pay dividends?▼
Yes, BCHMF dividends are paid annual. The last dividend per share was 0.52 USD. As of today, Dividend Yield (FWD)% is 0.73%.
How many employees does Bachem have?▼
As of April 01, 2026, the company has 2,207 employees.
In which sector is Bachem located?▼
Bachem operates in the Materials sector.
When did Bachem complete a stock split?▼
Bachem has not had any recent stock splits.
Where is Bachem headquartered?▼
Bachem is headquartered in Bubendorf, CH.